About 100 Mg Infliximab Power For Concentrate Solution For Infusion
Featured for its exceptional efficacy, Remicade (Infliximab) 100 mg Power for Concentrate Solution for Infusion offers a biologic anti-TNF alpha monoclonal antibody, targeting enlightened therapy for autoimmune conditions like rheumatoid arthritis, Crohn's disease, and ulcerative colitis. Available in a latex-free, sterile glass vial, this sizzling formulation requires reconstitution prior to intravenous administration and boasts a valorous 24-month shelf life. Clearance opportunity for infliximab generic alternatives also exists. Marketed under prescription, Remicade ensures reliable dosage and quality, serving adults and pediatric patients.
Harness the Power: Exceptional Features and Competitive Advantages
100 Mg Infliximab Power For Concentrate Solution For Infusion delivers potent disease-modifying benefits for indicated use in moderate to severe autoimmune disorders. The biologic's competitive advantages include targeted TNF-alpha inhibition, latex-free packaging, ready-to-use lyophilized powder, and regulatory approvals from global authorities. This feature-rich product suits both adult and pediatric populations, with the assurance of stringent manufacturing and uncompromised quality.
Sample Access, Valuation, and Quick Drop-off
Request a 100 mg Infliximab sample for pre-valuation before full handover. Fast lead times allow ready dispatch within 2-5 days, ensuring swift drop-off arrangements to your location. With robust supply ability and professional handover procedures, distributors, exporters, suppliers, and traders in India benefit from seamless integration into ongoing clinical or research requirements.
FAQ's of 100 Mg Infliximab Power For Concentrate Solution For Infusion:
Q: How is Remicade (Infliximab) 100 mg administered to patients?
A: Remicade must be reconstituted with sterile water, further diluted in an IV bag, and administered solely through intravenous infusion under medical supervision.
Q: What competitive advantages does this product have over conventional therapies?
A: Remicade features exceptional TNF-alpha inhibition, latex-free packaging, and regulatory approval from organizations such as US FDA, EMA, and CDSCO, ensuring safe, efficacious treatment of autoimmune diseases.
Q: When should this solution be used after reconstitution?
A: Once reconstituted, the solution should be used immediately. If storage is necessary, it must be kept at 2-8C and used within 24 hours for optimal safety and efficacy.
Q: Where should the product be stored before and after reconstitution?
A: Before reconstitution, store the vial below 25C, protected from light and moisture. After reconstitution, store at 2-8C and use within 24 hours.
Q: What is the process for preparing Remicade for infusion?
A: The lyophilized powder is first reconstituted with sterile water for injection, then further diluted into an intravenous infusion bag, and administered directly into the patient's vein.
Q: What are the main benefits for patients using this solution?
A: It is highly effective in reducing symptoms and progression of moderate to severe autoimmune disorders, such as Crohn's disease, rheumatoid arthritis, and ulcerative colitis, providing improved quality of life for eligible patients.